Company / Current Assets per Share
Oruka Therapeutics, Inc. Current Assets per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$0.00
FY2024
5-year range
$0.00 / $31.35
FY2020-FY2024
Trend
-100.0%
vs FY2023
Sector context
#210 of 210
Health Care
What the data says
Among 210 Health Care companies, Oruka Therapeutics, Inc. is in the bottom 0% for current assets per share. Current Assets per Share has declined for 4 consecutive years, from $31.35 in FY2020 to $0.00 in FY2024.
Based on SEC 10-K filings.
0.00 in FY2024 with a 5-year CAGR of -91.1%.
Declined from $2.96 to $0.00 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -97.8%
- 5-Year CAGR
- -91.1%
- 10-Year CAGR
- -
Sector benchmark
Bottom 0% in Health CareTop 100% of 210This company $0.00 Sector average $134.38
▼
-100.0% below sector average
Key checks
Key Insights
- Oruka Therapeutics, Inc.'s current assets per share has declined for 4 consecutive years.
- In FY2024, current assets per share decreased 100.0% year-over-year.
- Ranks #210 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.00 | -100.0% |
| FY2023 | $2.61 | -12.0% |
| FY2022 | $2.96 | -48.0% |
| FY2021 | $5.70 | -81.8% |
| FY2020 | $31.35 | +185.9% |
| FY2019 | $10.96 | +1804.7% |
| FY2018 | $0.58 | -57.5% |
| FY2017 | $1.35 | -42.8% |
| FY2016 | $2.37 | -81.6% |
| FY2015 | $12.88 | +1204.4% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026